Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dual therapy for Helicobacter pylori eradication in real-world multicenter practice
ChiCTR2500103678Phase 4Not yet recruiting
- Sponsor
- Fujian Provincial Hospital
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of amoxicillin, minocycline, doxycycline and vonoprazan in Helicobacter pylori infection (2 arms), sponsored by Fujian Provincial Hospital. Primary endpoint: Eradication rate. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
amoxicillinminocyclinedoxycyclinevonoprazan
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on ChiCTR2500103678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500103678.